KLI

Mutation in Genes Encoding Key Functional Groups Additively Increase Mortality in Patients with BRAF(V600E)-Mutant Advanced Papillary Thyroid Carcinoma

Metadata Downloads
Abstract
Simple SummaryThe BRAF(V600E) point mutation is the most common driver mutation in papillary thyroid carcinoma (PTC) and is known to be associated with aggressive clinical features. However, the negative prognostic impact of BRAF(V600E) on PTC mostly depends on tumor characteristics, not on itself. Moreover, the prognosis of BRAF(V600E)-mutant PTCs varies widely implying the genetic diversity of this subtype. Additional genetic alterations other than BRAF(V600E) may be responsible for the aggressiveness of this group but to date, no mutations other than TERT promoter mutation have been identified. This study aimed to investigate the effect of additional genetic alterations, focusing on the mutations in genes encoding functional groups on survival in BRAF(V600E)-mutant PTCs. We observed that coexistence of mutations in BRAF(V600E) and the three functional groups had the worst survival in patients with PTCs compared with mutations in BRAF(V600E) and genes other than those associated with functional groups or mutations in only BRAF(V600E).The prognosis of BRAF(V600E)-mutant papillary thyroid carcinoma (PTC) ranges from indolent to highly aggressive courses. To better define the genetic diversity of this subtype, we evaluated the survival according to the presence of an additional mutation in genes encoding functional groups (FGs) in BRAF(V600E)-mutant advanced PTC patients. Targeted next-generation sequencing was performed in primary tumors of 50 BRAF(V600E)-mutant PTCs with distant metastasis or aggressive variants. The mutation in genes encoding FGs included alterations in histone methyltransferases, SWI/SNF subunit, and the PI3K/AKT/mTOR pathway. The primary outcome was overall survival (OS). Fifteen patients only had the BRAF(V600E)-mutation (group 1), 22 had BRAF(V600E) and mutation other than FGs (group 2), and 13 had BRAF(V600E) and FG mutation (group 3). OS was significantly lower in patients with FG mutations (p = 0.001) than those without, and group 3 patients had the worst survival (p = 0.004). OS significantly varied among none, one, or two FG mutation sites (p = 0.005). Presence of FG mutation was independently associated with increased mortality (hazard ratio 11.65, 95% confidence interval 1.39-97.58, p = 0.024). Coexistence of mutations in BRAF(V600E) and genes encoding FGs was associated with high mortality. Identification of FG mutation in BRAF(V600E)-mutant PTCs may be valuable in risk stratifying this subtype.
Author(s)
송의연김미화장아름전민지송동은류혜진김원배송영기김원구
Issued Date
2021
Type
Article
Keyword
BRAFfunctional groupsgenetic mutationpapillary thyroid carcinoma
DOI
10.3390/cancers13225846
URI
https://oak.ulsan.ac.kr/handle/2021.oak/7225
https://ulsan-primo.hosted.exlibrisgroup.com/primo-explore/fulldisplay?docid=TN_cdi_doaj_primary_oai_doaj_org_article_a84d0ba8a0654c78b83d51e726ac5ecd&context=PC&vid=ULSAN&lang=ko_KR&search_scope=default_scope&adaptor=primo_central_multiple_fe&tab=default_tab&query=any,contains,Mutation%20in%20Genes%20Encoding%20Key%20Functional%20Groups%20Additively%20Increase%20Mortality%20in%20Patients%20with%20BRAF(V600E)-Mutant%20Advanced%20Papillary%20Thyroid%20Carcinoma&offset=0&pcAvailability=true
Publisher
CANCERS
Location
스위스
Language
영어
ISSN
2072-6694
Citation Volume
13
Citation Number
0
Citation Start Page
0
Citation End Page
0
Appears in Collections:
Medicine > Medicine
Authorize & License
  • Authorize공개
Files in This Item:
  • There are no files associated with this item.

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.